$GLUE

$10.50▲ -6.8% YTD

8 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

News

GLUE ▼ -6.8% - Monte Rosa Therapeutics, Inc.

CP $10.50▲ -6.8%Oct 2, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News

GLUE ▲ +15.0% - Monte Rosa Therapeutics, Inc.

CP $13.71▲ +15.0%Oct 1, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of A…

News

GLUE ▲ +5.8% - Monte Rosa Therapeutics, Inc.

CP $12.42▲ +5.8%Sep 30, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk…

News

GLUE ▲ +1.2% - Monte Rosa Therapeutics, Inc.

CP $14.00▲ +1.2%Sep 8, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue…

News

GLUE ▼ -0.5% - Monte Rosa Therapeutics, Inc.

CP $14.22▲ -0.5%Sep 2, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News

GLUE ▼ -0.2% - Monte Rosa Therapeutics, Inc.

CP $13.94▲ -0.2%Sep 1, 2026 · ThinkSabio Blog

$GLUE - Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences…

SEC 13D/G

$GLUE SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified

$23.35▲ 52.61%Jul 8, 2026 · ThinkSabio Blog

$GLUE SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #GLUE : $23.35 Sector: Healthcare | YTD: 🔼+ 52.61% The SEC discl…

SEC 13D/G

$GLUE SEC Filing Update (06-JUL-2026) | ThinkSabio - Stocks Simplified

$23.25▲ 51.96%Jul 6, 2026 · ThinkSabio Blog

$GLUE SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #GLUE : $23.25 Sector: Healthcare | YTD: 🔼+ 51.96% The SEC discl…